PortfoliosLab logo
XLV vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between XLV and LLY is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

XLV vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Health Care Select Sector SPDR Fund (XLV) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

1,000.00%1,500.00%2,000.00%NovemberDecember2025FebruaryMarchApril
709.28%
2,007.03%
XLV
LLY

Key characteristics

Sharpe Ratio

XLV:

-0.05

LLY:

0.54

Sortino Ratio

XLV:

0.03

LLY:

1.01

Omega Ratio

XLV:

1.00

LLY:

1.13

Calmar Ratio

XLV:

-0.05

LLY:

0.79

Martin Ratio

XLV:

-0.12

LLY:

1.61

Ulcer Index

XLV:

6.00%

LLY:

12.05%

Daily Std Dev

XLV:

14.30%

LLY:

36.25%

Max Drawdown

XLV:

-39.17%

LLY:

-68.27%

Current Drawdown

XLV:

-11.14%

LLY:

-7.55%

Returns By Period

In the year-to-date period, XLV achieves a 0.74% return, which is significantly lower than LLY's 14.78% return. Over the past 10 years, XLV has underperformed LLY with an annualized return of 8.56%, while LLY has yielded a comparatively higher 31.05% annualized return.


XLV

YTD

0.74%

1M

-4.48%

6M

-6.31%

1Y

0.23%

5Y*

8.49%

10Y*

8.56%

LLY

YTD

14.78%

1M

7.54%

6M

-0.58%

1Y

21.37%

5Y*

43.19%

10Y*

31.05%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

XLV vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XLV
The Risk-Adjusted Performance Rank of XLV is 1818
Overall Rank
The Sharpe Ratio Rank of XLV is 1919
Sharpe Ratio Rank
The Sortino Ratio Rank of XLV is 1717
Sortino Ratio Rank
The Omega Ratio Rank of XLV is 1717
Omega Ratio Rank
The Calmar Ratio Rank of XLV is 1818
Calmar Ratio Rank
The Martin Ratio Rank of XLV is 1919
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 7171
Overall Rank
The Sharpe Ratio Rank of LLY is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 6767
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 6565
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 8181
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 7171
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

XLV vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Health Care Select Sector SPDR Fund (XLV) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for XLV, currently valued at -0.05, compared to the broader market-1.000.001.002.003.004.00
XLV: -0.05
LLY: 0.54
The chart of Sortino ratio for XLV, currently valued at 0.03, compared to the broader market-2.000.002.004.006.008.00
XLV: 0.03
LLY: 1.01
The chart of Omega ratio for XLV, currently valued at 1.00, compared to the broader market0.501.001.502.002.50
XLV: 1.00
LLY: 1.13
The chart of Calmar ratio for XLV, currently valued at -0.05, compared to the broader market0.002.004.006.008.0010.0012.00
XLV: -0.05
LLY: 0.79
The chart of Martin ratio for XLV, currently valued at -0.12, compared to the broader market0.0020.0040.0060.00
XLV: -0.12
LLY: 1.61

The current XLV Sharpe Ratio is -0.05, which is lower than the LLY Sharpe Ratio of 0.54. The chart below compares the historical Sharpe Ratios of XLV and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
-0.05
0.54
XLV
LLY

Dividends

XLV vs. LLY - Dividend Comparison

XLV's dividend yield for the trailing twelve months is around 1.69%, more than LLY's 0.61% yield.


TTM20242023202220212020201920182017201620152014
XLV
Health Care Select Sector SPDR Fund
1.69%1.67%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%
LLY
Eli Lilly and Company
0.61%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

XLV vs. LLY - Drawdown Comparison

The maximum XLV drawdown since its inception was -39.17%, smaller than the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for XLV and LLY. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%NovemberDecember2025FebruaryMarchApril
-11.14%
-7.55%
XLV
LLY

Volatility

XLV vs. LLY - Volatility Comparison

The current volatility for Health Care Select Sector SPDR Fund (XLV) is 9.15%, while Eli Lilly and Company (LLY) has a volatility of 18.64%. This indicates that XLV experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
9.15%
18.64%
XLV
LLY